As an affordability crisis grows in pricey New England, the rising cost of prescription drugs is squeezing patients, health ...

When I heard that Michelle Trachtenberg died of diabetes complications, my heart sank. On February 26, the 39-year-old ...

Dexcom has been cash flow positive for since 2014 and more recently moved into positive earnings territory. While revenue has grown very quickly, research and development expenses and selling, general ...

Tandem Diabetes Care, Inc.’s TNDM impressive international expansion is expected to bolster growth in the upcoming quarters. A robust diabetes market provides a favorable opportunity for the company’s ...

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

Communities that have become integrated by free trade are facing a rude awakening, as President Trump’s tariffs disrupt a way ...

The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...

Pharmacy benefit managers (PBMs) in the US forced companies in the diabetes market to lower prices last ... to administer insulin with needle-free devices, and insulin pumps, which also make ...

The pump-based platform will be a hybrid closed ... like Novo Nordisk and Sanofi in an increasingly crowded and price-conscious insulin market. Lilly has been under pressure in the US over its ...

As we’ve been reporting, US Vice-President JD Vance says there is a “good chance” that the US and UK will come to a mutually ...

On Jan. 7, the Consumer Financial Protection Bureau issued a new rule prohibiting consumer reporting agencies from including ...